Literature DB >> 23279046

Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency.

J P Galanaud1, C A Holcroft, M A Rodger, M J Kovacs, M T Betancourt, P S Wells, D R Anderson, I Chagnon, G Le Gal, S Solymoss, M A Crowther, A Perrier, R H White, L M Vickars, T Ramsay, S R Kahn.   

Abstract

BACKGROUND: Post-thrombotic syndrome (PTS) is the most frequent complication of deep vein thrombosis (DVT). Its diagnosis is based on clinical characteristics. However, symptoms and signs of PTS are non-specific, and could result from concomitant primary venous insufficiency (PVI) rather than DVT. This could bias evaluation of PTS.
METHODS: Using data from the REVERSE multicenter study, we assessed risk factors for PTS in patients with a first unprovoked unilateral proximal DVT 5-7 months earlier who were free of clinically significant PVI (defined as absence of moderate or severe venous ectasia in the contralateral leg).
RESULTS: Among the 328 patients considered, the prevalence of PTS was 27.1%. Obesity (odds ratio [OR] 2.6 [95% confidence interval (CI) 1.5-4.7]), mild contralateral venous ectasia (OR 2.2 [95% CI 1.1-4.3]), poor International Normalized Ratio (INR) control (OR per additional 1% of time with INR < 2 during anticoagulant treatment of 1.018 [95% CI 1.003-1.034]) and the presence of residual venous obstruction on ultrasound (OR 2.1 [95% CI 1.1-3.7]) significantly increased the risk for PTS in multivariable analyses. When we restricted our analysis to patients without any signs, even mild, of contralateral venous insufficiency (n = 244), the prevalence of PTS decreased slightly to 24.6%. Only obesity remained an independent predictor of PTS (OR 2.6 [95% CI 1.3-5.0]). Poor INR control and residual venous obstruction also increased the risk, but the results were no longer statistically significant (OR 1.017 [95% CI 0.999-1.035] and OR 1.7 [95% CI 0.9-3.3], respectively).
CONCLUSIONS: After a first unprovoked proximal DVT, obese patients and patients with even mild PVI constitute a group at increased risk of developing PTS for whom particular attention should be paid with respect to PTS prevention. Careful monitoring of anticoagulant treatment may prevent PTS.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23279046     DOI: 10.1111/jth.12106

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  17 in total

Review 1.  Medical Treatment for Postthrombotic Syndrome.

Authors:  Federico Silva Palacios; Suman Wasan Rathbun
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

Review 2.  The Future of Nanoparticle-Directed Venous Therapy.

Authors:  Benjamin Jacobs; Chandu Vemuri
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

3.  Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis.

Authors:  Elham E Amin; Ingrid M Bistervels; Karina Meijer; Lidwine W Tick; Saskia Middeldorp; Guy Mostard; Marlène van de Poel; Erik H Serné; Hans M Otten; Edith M Klappe; Manuela A Joore; Hugo Ten Cate; Marije Ten Wolde; Arina J Ten Cate-Hoek
Journal:  Blood       Date:  2018-09-20       Impact factor: 22.113

Review 4.  Treating infrainguinal deep venous thrombosis.

Authors:  Suresh Vedantham
Journal:  Tech Vasc Interv Radiol       Date:  2014-06

5.  The post-thrombotic syndrome: a 2012 therapeutic update.

Authors:  Jean-Philippe Galanaud; Susan R Kahn
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04

6.  Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry.

Authors:  Yuji Nishimoto; Yugo Yamashita; Takeshi Morimoto; Syunsuke Saga; Hidewo Amano; Toru Takase; Seiichi Hiramori; Kitae Kim; Maki Oi; Masaharu Akao; Yohei Kobayashi; Mamoru Toyofuku; Toshiaki Izumi; Tomohisa Tada; Po-Min Chen; Koichiro Murata; Yoshiaki Tsuyuki; Tomoki Sasa; Jiro Sakamoto; Minako Kinoshita; Kiyonori Togi; Hiroshi Mabuchi; Kensuke Takabayashi; Hiroki Shiomi; Takao Kato; Takeru Makiyama; Koh Ono; Yukihito Sato; Takeshi Kimura
Journal:  Heart Vessels       Date:  2018-10-06       Impact factor: 2.037

Review 7.  Prevention of the Post-Thrombotic Syndrome.

Authors:  Teresa L Carman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08

8.  Pediatric May-Thurner Syndrome-Systematic review and individual patient data meta-analysis.

Authors:  Laura Avila; Noelle Cullinan; Michael White; Marian Gaballah; Anne Marie Cahill; Deepti Warad; Vilmarie Rodriguez; Cristina Tarango; Anna Hoppmann; Stephen Nelson; Tomas Kuhn; Tina Biss; Aaron Weiss; Michael Temple; João G Amaral; Nour Amiri; Ana C Xavier; Samuele Renzi; Leonardo R Brandão
Journal:  J Thromb Haemost       Date:  2021-04-01       Impact factor: 5.824

9.  Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children.

Authors:  Laura Avila; Nour Amiri; Riddhita De; Jennifer Vincelli; Eleanor Pullenayegum; Suzan Williams; Leonardo R Brandão
Journal:  Blood Adv       Date:  2021-10-12

Review 10.  Guidance for the prevention and treatment of the post-thrombotic syndrome.

Authors:  Susan R Kahn; Jean-Philippe Galanaud; Suresh Vedantham; Jeffrey S Ginsberg
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.